Scinai Immunotherapeutics (SCNI) EPS (Basic) (2014 - 2024)
Scinai Immunotherapeutics' (SCNI) quarterly EPS (Basic) came in at -$0.0 in Q4 2024, up 39.86% year-on-year from -$0.0 in Q1 2024, and up 100.0% quarter-over-quarter from -$2.9 million in Q2 2024.
Scinai Immunotherapeutics (SCNI) EPS (Basic) (2014 - 2024) Analysis & Trends
Scinai Immunotherapeutics has disclosed EPS (Basic) across 8 years of filings, most recently posting -$0.0 for Q4 2024.
- EPS (Basic) for Q4 2024 came in at -$0.0, up 39.86% year-over-year; the trailing twelve-month figure through Dec 2025 was -$2.9 million (down 17.24% YoY), and the FY2025 annual result was $0.0, up 133.61% from the prior year.
- EPS (Basic) came in at -$0.0 for Q4 2024 at Scinai Immunotherapeutics, up from -$2.9 million in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $690500.0 in Q2 2022 to a low of -$10.0 million in Q1 2020.
- The 5-year median for EPS (Basic) is -$0.0 (2022), against an average of -$840642.9.
- Across the five-year window, EPS (Basic) jumped 6811193898.55% in 2022 and plunged 780.12% in 2024, its largest moves.
- Scinai Immunotherapeutics' EPS (Basic) stood at -$0.03 in 2020, then soared by 208.83% to $0.03 in 2021, then tumbled by 190.82% to -$0.03 in 2022, then jumped by 95.39% to -$0.0 in 2023, then soared by 39.86% to -$0.0 in 2024.
- The last three EPS (Basic) figures came in at -$0.0 (Q4 2024), -$2.9 million (Q2 2024), and -$0.0 (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 0.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.06 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.06 |
| 10 | Scinai Immunotherapeutics | 3.02 Bn | 988.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 0.00 |
| Jun 30, 2024 | -2.94 Mn |
| Dec 31, 2023 | 0.00 |
| Jun 30, 2023 | 432,500.00 |
| Mar 31, 2023 | 0.00 |
| Dec 31, 2022 | -0.03 |
| Jun 30, 2022 | 690,500.00 |
| Mar 31, 2022 | 0.00 |
| Dec 31, 2021 | 0.03 |
| Sep 30, 2021 | -0.01 |
| Jun 30, 2021 | -0.01 |
| Dec 31, 2020 | -0.03 |
| Sep 30, 2020 | 0.12 |
| Mar 31, 2020 | -9.95 Mn |
| Mar 31, 2019 | -2.57 Mn |
| Sep 30, 2015 | -0.02 |
| Dec 31, 2014 | -0.04 |
| Sep 30, 2014 | -0.04 |